Accéder au contenu
Merck
Toutes les photos(1)

Key Documents

View All Documentation

Y0001130

Cimetidine for peak identification

European Pharmacopoeia (EP) Reference Standard

Synonyme(s) :

Cimetidine, SKF-92334

Se connecterpour consulter vos tarifs contractuels et ceux de votre entreprise/organisme
Toutes les photos(1)

About This Item

Formule empirique (notation de Hill):
C10H16N6S
Numéro CAS:
51481-61-9
Poids moléculaire :
252.34
Numéro MDL:
MFCD00133296
Code UNSPSC :
41116107
ID de substance PubChem :
329831280
Nomenclature NACRES :
NA.24

Qualité

pharmaceutical primary standard

Famille d'API

cimetidine

Fabricant/nom de marque

EDQM

Application(s)

pharmaceutical (small molecule)

Format

neat

Température de stockage

2-8°C

Chaîne SMILES 

CN\C(NC#N)=N\CCSCc1nc[nH]c1C

InChI

1S/C10H16N6S/c1-8-9(16-7-15-8)5-17-4-3-13-10(12-2)14-6-11/h7H,3-5H2,1-2H3,(H,15,16)(H2,12,13,14)

Clé InChI

AQIXAKUUQRKLND-UHFFFAOYSA-N

Informations sur le gène

human ... HRH2(3274)

Vous recherchez des produits similaires ? Visite Guide de comparaison des produits

Description générale

This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the issuing Pharmacopoeia.For further information and support please go to the website of the issuing Pharmacopoeia.

Application

Cimetidine for peak identification EP Reference standard, intended for use in laboratory tests only as specifically prescribed in the European Pharmacopoeia.

Conditionnement

The product is delivered as supplied by the issuing Pharmacopoeia. For the current unit quantity, please visit the EDQM reference substance catalogue.

Autres remarques

Sales restrictions may apply.

Produit(s) apparenté(s)

Réf. du produit
Description
Tarif

PHR1075

Cimetidine, Pharmaceutical Secondary Standard; Certified Reference Material

PHR1089

Cimetidine hydrochloride, Pharmaceutical Secondary Standard; Certified Reference Material

1134073

Cimetidine hydrochloride, United States Pharmacopeia (USP) Reference Standard

C2175500

Cimetidine hydrochloride, European Pharmacopoeia (EP) Reference Standard

C2175000

Cimetidine, European Pharmacopoeia (EP) Reference Standard

Y0001146

Cimetidine for system suitability, European Pharmacopoeia (EP) Reference Standard

1134062

Cimetidine, United States Pharmacopeia (USP) Reference Standard

BP475

Cimetidine, British Pharmacopoeia (BP) Reference Standard

PHR2242

Cimetidine Impurity D, Pharmaceutical Secondary Standard; Certified Reference Material

PHR2220

Cimetidine Impurity A, Pharmaceutical Secondary Standard; Certified Reference Material

PHR2250

Cimetidine Impurity B, pharmaceutical secondary standard, certified reference material

PHR2251

Cimetidine Impurity C, Pharmaceutical Secondary Standard; Certified Reference Material

PHR2252

Cimetidine Impurity J, certified reference material, pharmaceutical secondary standard

PHR2259

Cimetidine Impurity G, Pharmaceutical Secondary Standard; Certified Reference Material

PHR2260

Cimetidine Impurity I, Pharmaceutical Secondary Standard; Certified Reference Material

PHR2255

Cimetidine Impurity H

PHR2243

Cimetidine Impurity E, Pharmaceutical Secondary Standard; Certified Reference Material

Code de la classe de stockage

11 - Combustible Solids

Classe de danger pour l'eau (WGK)

WGK 3

Faites votre choix parmi les versions les plus récentes :

Certificats d'analyse (COA)

Lot/Batch Number

Désolés, nous n'avons pas de COA pour ce produit disponible en ligne pour le moment.

Si vous avez besoin d'assistance, veuillez contacter Service Clients

Déjà en possession de ce produit ?

Retrouvez la documentation relative aux produits que vous avez récemment achetés dans la Bibliothèque de documents.

Consulter la Bibliothèque de documents

J E Naschitz et al.
Seminars in arthritis and rheumatism, 21(4), 211-220 (1992-02-01)
The term fasciitis-panniculitis syndrome (FPS) is proposed as a novel compilation encompassing several disorders, common to which is subcutaneous induration caused by cicatrizing fasciitis as well as septal and lobular panniculitis and perimysial fibrosis. Included herein are Shulman's eosinophilic fasciitis
P San Miguel et al.
Virchows Archiv : an international journal of pathology, 430(3), 261-263 (1997-03-01)
A case of carcinoma in the breast of a male patient with a chronic gastric ulcer is described. The patient had received cimetidine for 17 years. Histological examination of an excisional biopsy showed lobular in situ and infiltrating carcinoma. In
A F Shinn
Drug safety, 7(4), 245-267 (1992-07-01)
The excellent efficacy and tolerability profiles of H2-antagonists have established these agents as the leading class of antiulcer drugs. Attention has been focused on drug interactions with H2-antagonists as a means of product differentiation and because many patients are receiving
Cimetidine in idiopathic urticaria.
M Choy et al.
DICP : the annals of pharmacotherapy, 25(6), 609-612 (1991-06-01)
A Kumar
DICP : the annals of pharmacotherapy, 24(3), 289-295 (1990-03-01)
Suppressor T lymphocytes possess histamine2 (H2) receptors and contribute significantly to the function of the immune system. Experimentally, cimetidine, an H2-receptor antagonist, has been shown to enhance a variety of immunologic functions both in vivo and in vitro because of
Afficher tous les articles scientifiques apparentés

Notre équipe de scientifiques dispose d'une expérience dans tous les secteurs de la recherche, notamment en sciences de la vie, science des matériaux, synthèse chimique, chromatographie, analyse et dans de nombreux autres domaines..

Contacter notre Service technique